Autolus Therapeutics PLCNASDAQ:AUTL
- LAST PRICE4.2500
- TODAY'S CHANGE (%)-0.1000 (-2.2989%)
- Bid / Lots4.2000/ 2
- Ask / Lots4.5600/ 50
- Open / Previous Close4.3300 / 4.3500
- Day Range
- 52 Week Range
- Volume892,003
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AUTL |
|---|---|---|
| 02:24 ET | 426 | 4.225 |
| 02:26 ET | 686 | 4.225 |
| 02:27 ET | 500 | 4.225 |
| 02:29 ET | 1927 | 4.225 |
| 02:31 ET | 4384 | 4.22 |
| 02:33 ET | 1814 | 4.22 |
| 02:38 ET | 25384 | 4.21 |
| 02:40 ET | 2259 | 4.22 |
| 02:42 ET | 1816 | 4.225 |
| 02:44 ET | 200 | 4.23 |
| 02:45 ET | 2000 | 4.225 |
| 02:47 ET | 600 | 4.225 |
| 02:49 ET | 700 | 4.225 |
| 02:54 ET | 2070 | 4.225 |
| 02:56 ET | 1000 | 4.225 |
| 02:58 ET | 900 | 4.225 |
| 03:00 ET | 100 | 4.225 |
| 03:02 ET | 100 | 4.225 |
| 03:03 ET | 553 | 4.225 |
| 03:05 ET | 18500 | 4.265 |
| 03:07 ET | 5117 | 4.265 |
| 03:09 ET | 1440 | 4.27 |
| 03:12 ET | 2587 | 4.275 |
| 03:14 ET | 3536 | 4.275 |
| 03:16 ET | 900 | 4.275 |
| 03:18 ET | 1136 | 4.275 |
| 03:20 ET | 1200 | 4.275 |
| 03:21 ET | 1100 | 4.275 |
| 03:23 ET | 20873 | 4.295 |
| 03:25 ET | 2899 | 4.285 |
| 03:27 ET | 2600 | 4.26 |
| 03:30 ET | 1277 | 4.255 |
| 03:32 ET | 2700 | 4.255 |
| 03:34 ET | 700 | 4.255 |
| 03:36 ET | 4689 | 4.255 |
| 03:38 ET | 18103 | 4.27 |
| 03:39 ET | 4890 | 4.255 |
| 03:41 ET | 1272 | 4.26 |
| 03:43 ET | 6573 | 4.265 |
| 03:45 ET | 4349 | 4.26 |
| 03:48 ET | 6321 | 4.26 |
| 03:50 ET | 138 | 4.265 |
| 03:52 ET | 3871 | 4.265 |
| 03:54 ET | 110568 | 4.255 |
| 03:56 ET | 23658 | 4.245 |
| 03:57 ET | 13210 | 4.26 |
| 03:59 ET | 32257 | 4.25 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Autolus Therapeutics PLC | 1.2B | -3.5x | --- |
Enliven Therapeutics Inc | 1.1B | -11.4x | --- |
ARS Pharmaceuticals Inc | 1.1B | -20.3x | --- |
Pharvaris NV | 988.1M | -7.1x | --- |
Cullinan Therapeutics Inc | 1.1B | -5.8x | --- |
Tyra Biosciences Inc | 1.1B | -11.7x | --- |
Company Information
Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using a suite of proprietary and modular T cell programming technologies, it is engineering targeted, controlled and highly active T cell therapy product candidates that are designed to recognize target cells, break down their defense mechanisms and eliminate these cells. It has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. Its products pipeline includes obe-cel (FELIX), obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting T Cell Receptor Beta Constant (TRBC) 1 and TRBC 2.
Contact Information
- Headquarters
- The Mediaworks, 191 Wood LaneLONDON, United Kingdom W12 7FP
- Phone
- 203-829-6230
- Fax
- ---
Executives
- Chairman of the Board
- Michael Bonney
- Chief Executive Officer, Executive Director
- Christian Itin
- Founder, Senior Vice President, Chief Scientific Officer
- Martin Pule
- Chief Financial Officer, Senior Vice President
- Lucinda Crabtree
- Chief Operating Officer, Senior Vice President
- Christopher Vann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
|---|---|
Revenue (TTM) | $10.5M |
Shares Outstanding | 266.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.12 |
EPS | $-1.21 |
Book Value | --- |
P/E Ratio | -3.5x |
Price/Sales (TTM) | 112.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,670.52% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
